Monday, March 22, 2021 10:17:19 AM
https://www.bbc.com/news/health-56352128
Here is an additional article stating that KNSA and HGEN are the two companies with the best GM-CSF drugs to combat Covid:
https://www.clinicaltrialsarena.com/comment/humanigens-and-kiniksas-anti-gm-csf-antibodies-likely-to-garner-a-place-for-nonventilated-covid-19-patients/
Recent KNSA News
- Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution • GlobeNewswire Inc. • 04/23/2024 11:30:00 AM
- Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024 • GlobeNewswire Inc. • 04/16/2024 08:01:00 PM
- Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart • GlobeNewswire Inc. • 04/02/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:34:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:31:55 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 10:29:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:26:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 12:35:20 PM
- Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution • GlobeNewswire Inc. • 02/28/2024 12:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2024 10:06:25 PM
- Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024 • GlobeNewswire Inc. • 02/21/2024 09:01:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:39:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 08:46:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:30:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 12:37:35 PM
- Kiniksa Pharmaceuticals Provides Corporate Update • GlobeNewswire Inc. • 01/04/2024 12:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/03/2024 09:55:41 PM
- Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/02/2024 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2023 09:20:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/07/2023 09:46:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/02/2023 08:15:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 11:35:17 AM
- Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution • GlobeNewswire Inc. • 10/31/2023 11:30:00 AM
- Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023 • GlobeNewswire Inc. • 10/24/2023 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 11:07:40 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM